Results 111 to 120 of about 1,729,369 (285)
Virological and Immunological Antiretroviral Treatment Failure and Predictors Among HIV Positive Adult and Adolescent Clients in Southeast Ethiopia
HIV/AIDS: Research and Palliative Care, 2022 Ayele Mamo,1 Tesfaye Assefa,2 Wegene Negash,2 Yohannes Takelign,3 Biniyam Sahiledinigl,3 Zinash Teferu,3 Mesud Mohammed,1 Damtew Solomon,4 Habtamu Gezahegn,4 Kebebe Bekele,5 Demsu Zenbaba,3 Alelign Tasew,3 Anwar Tahir,2 Fikereab Desta,3 Tadele Regassa,4 ...Mamo A, Assefa T, Negash W, Takelign Y, Sahiledinigl B, Teferu Z, Mohammed M, Solomon D, Gezahegn H, Bekele K, Zenbaba D, Tasew A, Tahir A, Desta F, Regassa T, Takele A, Regassa Z, Atilaw D +17 moredoaj Comparison of adherence and virological failure between arms.
, 2018 Comparison of adherence and virological failure between arms.Jorge Vergas (5094764), Fernando Lozano (565454), Pilar Vázquez (5094740), María José Ríos-Villegas (5094767), José Hernández-Quero (760796), Ignacio de los Santos (527809), Juan Flores (5094773), María Carmen Fariñas (5094752), Isabel García-Mercé (5094746), Alberto Romero-Palacios (565447), María Luisa Montes (5094743), Isabel Sanjoaquín (5094761), María José Galindo (3210978), Juan Pasquau (3152613), Koldo Aguirrebengoa (5094758), Francisco Orihuela (5094770), Samantha Elizabeth de Jesus (5094749), Arkaitz Imaz (3210993), Carmen Hidalgo-Tenorio (544083), Coral García-Vallecillos (5094755) +19 morecore +1 more sourceResolving the biome debate: ecological and palaeo‐data concur that the extensive tree‐limited grassy biomes of central and north‐western Madagascar are largely anthropogenic
Biological Reviews, EarlyView.ABSTRACT
For millennia, human activities have transformed ecosystems globally. Determining which landscapes are predominantly anthropogenic is crucial to conservation and habitat restoration. Madagascar, a critically‐threatened biodiversity hotspot, is a prominent example.Grant S. Joseph, Sean Hixon, Colleen L. Seymour, Laurie R. Godfrey, Miguel Pedrono, Karen E. Samonds, Andrinajoro R. Rakotoarivelo, Brooke E. Crowley +7 morewiley +1 more sourceAssociation with virological failure, using a logistic regression model.
, 2018 Association with virological failure, using a logistic regression model.Winfried V. Kern (208415), Claudia J. de Dood (561700), Paul L. A. M. Corstjens (561702), Jürg Utzinger (39609), Herry Mapesi (4255984), Christoph Hatz (35423), Katarina Stete (213207), Emilio Letang (332013), Matthias C. Müller (5866148), Govert J. van Dam (271055), Tracy R. Glass (134725), Alex Ntamatungiro (727980), Robert Ndege (5009420), Maja Weisser (659648) +13 morecore +1 more sourceIncidence and Predictors of Virological Failure Among Adult HIV/AIDS Patients on Second-Line Anti-Retroviral Therapy, in Selected Public Hospital of Addis Ababa, Ethiopia: Retrospective Follow-Up Study
HIV/AIDS: Research and Palliative Care, 2022 Hamdi Fekredin Zakaria,1 Temam Beshir Raru,1 Fila Ahmed Hassen,2 Galana Mamo Ayana,1 Bedasa Taye Merga,2 Gebiso Roba Debele,3 Genet Kiflemariam,4 Sewnet Adem Kebede,5 Tadesse Awoke Ayele5 1Department of Epidemiology and Biostatistics, School of Public ...Zakaria HF, Raru TB, Hassen FA, Ayana GM, Merga BT, Debele GR, Kiflemariam G, Kebede SA, Ayele TA +8 moredoaj Adherence as a predictor of the development of class-specific resistance mutations: the Swiss HIV Cohort Study [PDF]
, 2013 BACKGROUND: Non-adherence is one of the strongest predictors of therapeutic failure in HIV-positive patients. Virologic failure with subsequent emergence of resistance reduces future treatment options and long-term clinical success.
METHODS: Prospective Jürg Böni (36157), Yerly, Sabine, von Wyl Viktor, Alexandra Calmy (36005), Dunja Nicca (336117), Glass, Tracy R, Swiss HIV Cohort Study,, Hansjakob Furrer (93994), Günthard Huldrych F., Vincent Aubert (297526), Jürg Böni, Aubert Vincent, Calmy, Alexandra, Bucher, Heiner C, Huldrych F. Günthard (173082), Böni, J., Cavassini Matthias, Viktor von Wyl, Swiss HIV Cohort Study, Günthard, Huldrych F., Enos Bernasconi (174329), Furrer, Hansjakob, Heiner C Bucher, Klimkait, Thomas, Hansjakob Furrer, Alexandra Calmy, Calmy Alexandra, Aubert, Vincent, Glass, T.R., Sabine Yerly (82534), Dunja Nicca, Yerly, S., Bucher, Heiner C., Tracy R. Glass (134725), Yerly Ferrillo, Sabine, Bucher Heiner C., Tracy R Glass, Nicca, D., Bernasconi, E., Wainberg, Mark, Thomas Klimkait (178911), Calmy, A., Günthard, Huldrych F, Enos Bernasconi, Heiner C. Bucher (134728), Cavassini, M., Matthias Cavassini (146654), Aubert, V., Glass, Tracy R., Böni, Jürg, Klimkait Thomas, Thomas Klimkait, Glass Tracy R., Bernasconi, Enos, Nicca Dunja, von Wyl, Viktor, Nicca, Dunja, von Wyl, V., Furrer Hansjakob, Bernasconi Enos, Sabine Yerly, Furrer, H., Viktor von Wyl (146506), Günthard, H.F., Böni Jürg, Klimkait, T., Yerly Sabine, Vincent Aubert, Bucher, H.C., Huldrych F Günthard, Cavassini, Matthias, Matthias Cavassini +71 morecore +3 more sourcesKaplan-Meier estimates of virological failure >50 copies/mL.
, 2017 Kaplan-Meier estimates of virological failure >50 copies/mL.Alessandro Cozzi-Lepri (195759), Carmela Pinnetti (782902), Antonella d’Arminio Monforte (2198545), Massimo Galli (120466), Cristina Mussini (237788), Massimo Andreoni (103649), Andrea Antinori (103654), Francesca Ceccherini-Silberstein (103660), Andrea De Luca (132288), Vincenzo Spagnuolo (319803), Antonella Castagna (255402), Benedetto Maurizio Celesia (316157), Nicola Gianotti (3162951) +12 morecore +1 more sourceThe rate of viral rebound after attainment of an HIV load < 50 copies/mL according to specific antiretroviral drugs in use: Results from a multicenter cohort study [PDF]
, 2005 Background. Relatively few data are available on the association between the use of specific antiretroviral drugs and the rate of viral rebound in those attaining a viral load (VL) 500 copies/ mL).Smith, CJ, Smith, C J, Phillips, AN, Porter, K, Scullard, G, Hill, T, Fisher, M, Phillips, A N, Easterbrook, P, Johnson, MA, Gilson, R, Sabin, C A, Gazzard, B, United Kingdom HIV Cohort Study, Matthias, R, Sabin, CA, Johnson, M A +16 morecore +1 more sourceStatus and future of recombinant adeno‐associated virus vector manufacturing
Biotechnology Progress, EarlyView.Abstract
Sixty years of adeno‐associated virus (AAV) research illustrates a trajectory marked by basic science exploration, iterative innovation, persistent challenges, a number of clinical setbacks, as well as commercial therapeutic triumphs. This continual evolution has led to recombinant AAV (rAAV) becoming a cornerstone of modern gene therapy ...Frank Agbogbo, David Dismukewiley +1 more source